Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Basilea Pharmaceutica)"
Count: 67
Selected: 0
NCT IDTitle
NCT04604132Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma
NCT04098692Mass Balance and Pharmacokinetics Study of Derazantinib in Healthy Male Subjects
NCT04087876Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations
NCT04045613Derazantinib and Atezolizumab in Patients With Urothelial Cancer
NCT03439124Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia
NCT03250299Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
NCT03230318Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma
NCT03138733Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
NCT03137173Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections
NCT02895360Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma
NCT02527681Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics
NCT02490800Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma
NCT01752920Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations
NCT01397929An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors
NCT01030731Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
NCT01026740Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers
NCT01026636A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
NCT01026558A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients
NCT00965042Effect of Ceftobiprole on Human Intestinal Microflora
NCT00771719Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia
NCT00771524Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone
NCT00770978Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU
NCT00529282A Study of Ceftobiprole in Patients With Fever and Neutropenia.
NCT00519675Alitretinoin in the Treatment of Chronic Hand Eczema
NCT00505258Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia
NCT00413439Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy
NCT00326287Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia
NCT00309621Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis
NCT00229008Ceftobiprole in Hospital Acquired Pneumonia
NCT00228982Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
NCT00210964Ceftobiprole in Hospital Acquired Pneumonia
NCT00210899Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
NCT00124475Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis
NCT00124436Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis
NCT01406171Drug Interaction Study of Isavuconazole and Midazolam
NCT01245140Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis
NCT00817063Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
NCT00413218Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
NCT03241550A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
NCT02128893A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole
NCT02128321A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine
NCT02059590A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects
NCT01884636A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate
NCT01884558A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Metformin
NCT01813461Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects
NCT01809860A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects
NCT01711827A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Prednisone in Healthy Adult Subjects
NCT01711489A Study to Assess the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Mycophenolate Mofetil in Healthy Adult Subjects
NCT01660477Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole
NCT01657890Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects